Navigation Links
BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
Date:6/3/2008

As baby boomers age drug-free treatments receive renewed attention in

clinical trials - David G. Genecov, MD, FACS, FAAP to begin Plantar

Fasciitis Study

FREDERICK, Md., June 3 /PRNewswire-FirstCall/ -- BioElectronics Corp. (BIEL), the maker of the ActiPatch(TM), a drug free anti-inflammatory patch, with an embedded battery operated microchip delivering continuous pulse therapy, specifically designed to speed healing, today announced that recent sales successes, particularly in the international arena, and careful expense controls have resulted in the Company recently achieving operating breakeven. Additionally, the company announced today that world renowned plastic surgeon David G. Genecov will develop, institute and complete a new research study on the use of ActiPatch therapy for the treatment of plantar fasciitis, a condition that affects tens of millions of people throughout the world. The double-blind randomized study will be completed in conjunction with leading podiatrists under Dr. Genecov's direction and supervision.

"These are clearly exciting times for all of us at BioElectronics Corporation. We are continuing to see increased user acceptance of our products not only within the general and plastic surgery related markets in the United States, but also throughout many parts of Europe and Asia," commented Andy Whelan, CEO and President of BioElectronics Corporation. "Over the past few months, our international distribution channels have seen a significant amount of success and our penetration of the general and plastic surgery markets as meaningfully increased. Combined with tight expense controls at the Company, these successes have allowed us to reach profitability sooner than we had previously expected. We are expecting our revenues to continue to grow throughout the remainder of 2008 and into 2009 as ActiPatch continues to gain increased acceptance in both the domestic and international marketp
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioElectronics Announces Major Clinical Trials
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... -- Inmark,s acquisition of Saf-T-Pak last week positioned Inmark ... Division 6.2.  For over 25 years, Saf-T-Pak has ... on IATA, ICAO, US DOT, Transport Canada, RID/ADR ... were particularly interested in Saf-T-Pak,s proprietary Learning Management ... programs," said David Oyler , Inmark President ...
(Date:4/21/2015)... April 21, 2015 Global cap ... World demand for caps and closures will exceed $55 billion ... exceed two trillion annually. Beverages will continue to account for ... and a number of smaller markets are expected to register ... Although the most developed markets -- the US, ...
(Date:4/21/2015)... 2015 The global dermatology diagnostic devices market ... from 2014 to 2019. North America ... shares in the global dermatology diagnostic devices market. The ... mainly attributed to a wide range of factors, such ... dermatologists, and technological advancements made in the field of ...
Breaking Medicine Technology:Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2World Caps & Closures Market 2World Caps & Closures Market 3Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3
... and NEW YORK, July 14, 2011 ... company leveraging its proprietary drug-delivery platforms to develop treatments ... announced that its lead product for oral mucositis, ... benefit network.  Reimbursement coverage for MuGard is now available ...
... BLUE BELL, Pa., July 14, 2011 Inovio Pharmaceuticals, ... in the development of therapeutic and preventive vaccines against ... cell and antibody responses were generated in its Phase ... for the prevention of avian H5N1 influenza delivered using ...
Cached Medicine Technology:Access Pharmaceuticals MuGard Added to CVS Caremark's Pharmacy Benefit Network 2Access Pharmaceuticals MuGard Added to CVS Caremark's Pharmacy Benefit Network 3Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 2Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 3Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 4Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 5Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 6Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 7Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 8Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 9
(Date:4/21/2015)... 21, 2015 Respected academic institution selects ... , Visage Imaging Inc. (“Visage”), a wholly owned ... signed a seven-year contract with University of Florida Health ... The deal furthers the penetration of Visage ... key area of the North American enterprise imaging market. ...
(Date:4/21/2015)... Chicago, IL (PRWEB) April 21, 2015 ... the online retailer known for innovation at its healthiest, ... supplements starting May 1st. , At Wojo Nutrition, they’ve ... health seekers with convenient solutions tailored to meet their ... designed to be blended with any beverage, has been ...
(Date:4/21/2015)... Now in its fifteenth year, the ... unite over 3,000 senior attendees from across the ... Collection Showplace on June 3 and 4. This ... and Kia are set to deliver headline and ... reshaping automotive as connectivity paves the way towards ...
(Date:4/21/2015)... 21, 2015 Carinsuranceshoppingsource.com has released ... comprehensive auto insurance plans . , Comprehensive ... coverage for numerous situations. The coverage limit can also ... auto insurance will protect a car against fire damage, ... Comparing quotes is no longer difficult and it can ...
(Date:4/21/2015)... According to a recent article published ... Wolf has made naloxone available for anyone to have ... a pharmacy without a doctor’s order- in an attempt ... addiction. Pennsylvania’s state police will also begin carrying naloxone ... Narcan) is an opiate overdose reversal medication. The medicine ...
Breaking Medicine News(10 mins):Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2Health News:Drug Rehab Philadelphia Comments on Gov. Wolf’s Decision to Make Naloxone Widely Available 2
... by many, because of its omega-3 fatty acids and, ... of farmed (mostly Atlantic salmon) and wild salmon fish// ... salmon, are contaminated with more environmental pollutants such as ... from Alaska. Many consumers have a choice between farm-raised ...
... hepatitis C virus infection is a bad prognostic ... renal transplant recipients//. ,Hepatitis C virus (HCV) infection ... the prevalence depends on the geographic area. Infections ... transplant recipients. ,Researchers from the Armed Forces ...
... British Indian psychiatrist apparently has plagiarised the work of ... his own in an article for a medical journal//. ... edition was written by Raj Persaud and went unnoticed ... Persaud is one of the youngest doctors to become ...
... Canadians are rushing to India and other Asian countries ... waiting//. ,According to a recent report, Canada is ... for three years for procedures such as knee replacement and ... now turning to the World Wide Web to find medical ...
... initiative for Center for Clinical Global Health Education was ... that improvement of medical care to patients would improve ... better way//, his initiative was to provide training by ... distance learning for healthcare providers. Bollinger said, “Don’t wait ...
... pre-eclampsia, the level of maternal serum leptin is increased ... TNF-á//. ,The research was conducted at University ... serum leptin concentration in women with pre-eclampsia and women ... leptin and several inflammatory cytokines. ,The study appears ...
Cached Medicine News:Health News:Indian Psychiatrist in UK Accused of plagiarism 2Health News:Indian Psychiatrist in UK Accused of plagiarism 3Health News:John Hopkins CGHH program provides Global Health education 2
Inquire...
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... in the QuickLoad™ Loader allows for ...
... designed to help you achieve one important ... procedure. All needles are engineered for exceptional ... for smooth entry and exit. A broad ... an ideal match with procedural needs and ...
Medicine Products: